[Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice]

L Y Deng1, Z C Yang, Y L Gong

  • 1Institute of Burn Research, Southwest Hospital, State Key Laboratory of Trauma, Burns and Combined Injury, the Third Military Medical University, Chongqing 400038, China.

Abstract

Insights

Bacteriophage therapy significantly enhanced survival rates in mice with sepsis caused by extensively drug-resistant Acinetobacter baumannii. This treatment effectively reduced bacterial load and inflammation, offering a promising alternative to antibiotics.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Therapeutic Strategies

Background:

  • Sepsis caused by extensively drug-resistant Acinetobacter baumannii poses a significant therapeutic challenge.
  • Conventional antibiotic treatments may have limitations in efficacy and contribute to further resistance.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of bacteriophages against extensively drug-resistant Acinetobacter baumannii-induced sepsis in a murine model.
  • To compare phage therapy with antibiotic treatment and control groups.

Main Methods:

  • Establishment of a sepsis model in BALB/c mice using extensively drug-resistant Acinetobacter baumannii.
  • Treatment groups included saline control, antibiotics (imipenem/cilastatin), and bacteriophage therapy.
  • Assessment of survival rates, white blood cell counts, bacterial load in blood and tissues, and bacterial culture positivity.

Main Results:

  • Bacteriophage treatment significantly increased mouse survival rates compared to the sepsis control group.
  • Phage therapy demonstrated comparable or slightly superior survival outcomes to antibiotic treatment.
  • Significant reductions in bacterial load and improved inflammatory markers were observed in the phage treatment group across multiple organs.

Conclusions:

  • Bacteriophages are effective in treating extensively drug-resistant Acinetobacter baumannii sepsis in mice.
  • Phage therapy offers a viable strategy for controlling inflammation and clearing bacterial infections.
  • This study supports the potential of phage therapy as an alternative or adjunct treatment for multidrug-resistant bacterial infections.

Related Concept Videos